Why is the timeline different for recovery and growth hormone peptides?
The two groups do different jobs, so they are judged on different clocks. A recovery peptide is used to support healing of a specific injury, and the question is whether that injury feels and works better. A growth hormone peptide such as sermorelin or tesamorelin raises your own growth hormone and IGF-1, and the question is whether that hormone change shows up in labs and in body composition. Hormone effects build over months.
| Recovery peptides | Growth hormone peptides | |
|---|---|---|
| Examples | BPC-157, TB-500 | Sermorelin, tesamorelin |
| What you are watching | Pain, function, range of motion | IGF-1, waist, body composition, recovery |
| What the evidence shows | Mostly animal studies and personal reports | Controlled trials, mainly of tesamorelin |
| Reasonable time to judge | Set with your provider for the injury | Two to three months for IGF-1; longer for body composition |
How fast do recovery peptides work?
There is no reliable answer from human trials, and it is better to know that up front. Personal accounts online often describe improvement within a few weeks, but personal accounts cannot separate the peptide from rest, rehab, time and expectation.
The research record is thin. A 2025 systematic review of BPC-157 found 36 studies, 35 of them in animals or cells. The single human study was a retrospective report in which 7 of 12 people with chronic knee pain described relief lasting more than six months after an injection, with no comparison group. TB-500 has even less human data.
Their supply status is also unsettled in 2026: BPC-157 and TB-500 left the FDA’s safety-concern list in April, but no final rule makes them eligible for compounding. Our BPC-157 page explains where that stands, and our answer on why injuries heal slower after 40 covers the factors that affect recovery whatever you use.
How long do growth hormone peptides take?
Longer, and the timeline is better documented. Tesamorelin has the strongest data because it went through FDA trials for HIV-associated abdominal fat.
| Time on treatment | What the evidence shows |
|---|---|
| First weeks | Too early to judge; your baseline labs are the reference point |
| 6 to 8 weeks | First follow-up labs and check-in at Ultimate Male |
| By 13 weeks | The tesamorelin label records IGF-1 elevations appearing as early as this point |
| 26 weeks | Label trials measured visceral fat down 18 percent and 14 percent in the two studies, against small changes on placebo; mean IGF-1 up by about 107 ng/mL |
The original 2007 tesamorelin trial in the New England Journal of Medicine reported the same pattern at 26 weeks: visceral fat fell 15.2 percent on tesamorelin while it rose 5.0 percent on placebo, and IGF-1 rose 81 percent. Those results come from people with HIV-associated fat gain, so a healthy man’s response may differ, but the time frame is the useful lesson. Sermorelin works through the same pathway with less trial data, so a similar schedule is a sensible starting point.
If you are weighing tesamorelin against a GLP-1 for belly fat, our comparison of tesamorelin and GLP-1 medicines for visceral fat sets the timelines side by side.
Why can early changes mislead you?
Because growth hormone moves water as well as fat and muscle. The tesamorelin label describes fluid retention linked to rising growth hormone, and a review of muscle changes with aging cautions that lean mass gains on growth hormone partly reflect water retention. A quick change on the scale or in a body composition reading in the first weeks may not be the change you are after.
That is why waist measurements, repeat body composition and IGF-1 over months are better guides than day-to-day impressions. Our guide to tracking body composition progress explains how to measure consistently.
What can slow your results down?
Most of the things that blunt a peptide are the same ones that blunt any body composition plan: short sleep, too little protein, inconsistent training and missed doses. Storage matters too, since a peptide that has been left warm or mixed too long may not deliver the dose on the label. If your IGF-1 has not moved by your follow-up, adherence and handling are the first things to check before concluding the peptide does not work for you.
How Ultimate Male tracks your progress
In our peptide therapy program, every plan starts with blood work, including IGF-1, metabolic and hormone markers, so there is a baseline to compare against. Your first recheck comes at six to eight weeks, drawn on site in San Gabriel or Downey, and the plan is adjusted from there as you respond.
Your provider reads the IGF-1 blood test alongside your measurements and how you feel, then decides whether to continue, adjust or stop. For how long a course runs once it is working, see our answer on whether you need to cycle peptides. The free 10-minute call is the place to ask what a realistic timeline looks like for your goal.
